Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy

Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.

http://medicalxpress.com/news/2013-11-therapy-stem-cells-bone-marrow.html